Xia Wen Shui

  • Citations Per Year
Learn More
BACKGROUND The purpose of this study was to assess the in vivo ability of glucosaminic acid-cobalt (II) chelate to reduce glycemia. METHODS Different concentrations of chelate solution were administrated to mice with diabetes induced by streptozotocin. RESULTS Daily oral administration of chelate solution 0.4 mL at various concentrations (0.32-0.4 g/mL)(More)
  • 1